Cammà C - Search Results

1

Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease.

Pennisi G, Enea M, Viganò M, Schepis F, de Ledinghen V, Berzigotti A, Wai-Sun Wong V, Fracanzani AL, Sebastiani G, Lara-Romero C, Bugianesi E, Svegliati-Baroni G, Marra F, Aghemo A, Valenti L, Calvaruso V, Colecchia A, Di Maria G, La Mantia C, Lin H, Mendoza YP, Pugliese N, Ravaioli F, Romero-Gomez M, Saltini D, Craxì A, Di Marco V, Cammà C, Petta S. Pennisi G, et al. Among authors: camma c. JHEP Rep. 2023 Jun 7;5(9):100809. doi: 10.1016/j.jhepr.2023.100809. eCollection 2023 Sep. JHEP Rep. 2023. PMID: 37538247 Free PMC article.

2

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

Cammà C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Craxì A, Cottone M. Cammà C, et al. Radiology. 2002 Jul;224(1):47-54. doi: 10.1148/radiol.2241011262. Radiology. 2002. PMID: 12091661 Review.

3

When and how to treat acute hepatitis C?

Licata A, Di Bona D, Schepis F, Shahied L, Craxí A, Cammà C. Licata A, et al. Among authors: camma c. J Hepatol. 2003 Dec;39(6):1056-62. doi: 10.1016/s0168-8278(03)00461-6. J Hepatol. 2003. PMID: 14642626

4

Interferon-alpha for HBeAg-positive chronic hepatitis B.

Craxì A, Di Bona D, Cammà C. Craxì A, et al. Among authors: camma c. J Hepatol. 2003;39 Suppl 1:S99-105. doi: 10.1016/s0168-8278(03)00154-5. J Hepatol. 2003. PMID: 14708686 Review. No abstract available.

5

Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data.

Cammà C, Di Bona D, Schepis F, Heathcote EJ, Zeuzem S, Pockros PJ, Marcellin P, Balart L, Alberti A, Craxì A. Cammà C, et al. Hepatology. 2004 Feb;39(2):333-42. doi: 10.1002/hep.20073. Hepatology. 2004. PMID: 14767986

6

The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based approach.

Cammà C, Di Bona D, Craxì A. Cammà C, et al. Curr Pharm Des. 2004;10(17):2123-30. doi: 10.2174/1381612043384321. Curr Pharm Des. 2004. PMID: 15279551 Review.

7

Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial.

Bruno S, Cammà C, Di Marco V, Rumi M, Vinci M, Camozzi M, Rebucci C, Di Bona D, Colombo M, Craxì A, Mondelli MU, Pinzello G. Bruno S, et al. Among authors: camma c. J Hepatol. 2004 Sep;41(3):474-81. doi: 10.1016/j.jhep.2004.05.012. J Hepatol. 2004. PMID: 15336451 Clinical Trial.

8

Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years.

Manno M, Cammà C, Schepis F, Bassi F, Gelmini R, Giannini F, Miselli F, Grottola A, Ferretti I, Vecchi C, De Palma M, Villa E. Manno M, et al. Among authors: camma c. Gastroenterology. 2004 Sep;127(3):756-63. doi: 10.1053/j.gastro.2004.06.021. Gastroenterology. 2004. PMID: 15362032

9

Treatment of hepatitis C: critical appraisal of the evidence.

Cammà C, Licata A, Cabibbo G, Latteri F, Craxì A. Cammà C, et al. Expert Opin Pharmacother. 2005 Mar;6(3):399-408. doi: 10.1517/14656566.6.3.399. Expert Opin Pharmacother. 2005. PMID: 15794731 Review.

10

Prevention of hepatocellular carcinoma.

Craxì A, Cammà C. Craxì A, et al. Among authors: camma c. Clin Liver Dis. 2005 May;9(2):329-46, viii. doi: 10.1016/j.cld.2004.12.008. Clin Liver Dis. 2005. PMID: 15831277 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

397 results

Search Page